Patent · US Active

Poly (ADP-ribose) polymerase (PARP) inhibitors

US8669249B2 · kind B2 · utility

34Cited by

2References

12Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Jason W. Brown · San Diego, US
Anthony R. Gangloff · San Diego, US
Andrew John Jennings · Village of La Jolla, US
Phong Vu · San Diego, US

Key dates

Filing date	Mar 26, 2010
Grant date	Mar 11, 2014
Priority date	—
Expiry date	Sep 15, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the following formula are provided for use in inhibiting Poly (ADP-ribose) Polymerase (PARP):wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.